when did semaglutide hit the market Size, Share & Trends Report, 2025-2035 The Semaglutide Shortage Is Ending:

Alexander Shapsis, MD is a board-certified gastroenterologist and medical weight-loss specialist with extensive experience treating obesity and metabolic disorders using GLP-1 therapies, including semaglutide (Ozempic and Wegovy) and tirzepatide

Cohort study showing increased risk of diabetes and cardiovascular disorders in IIH

Bridge GLP-1 therapy with preconception plans by facilitating coordinated care between reproductive and obesity specialists

It does not predict your response to Ozempic or determine your dose

Treading the path of weight loss can indeed be a daunting endeavor

BodyTite & FaceTite BodyTite & FaceTite are minimally invasive treatments that utilize radiofrequency (RF) technology to destroy fat cells underneath the body